Pulmonology Conferences | Pulmonology Conferences 2023 | Top Pulmonology Conferences | Pulmonology Meetings | International Pulmonology Conferences | PULSUS Conferences | CME Conferences | USA | Europe | Asia

About Pulmonology Conferences

On behalf of the scientific board members of Pulsus conferences we welcome you all to the Leading Pulmonology Conferences 2023.

Pulmonology aims at the diseases, conditions and speciality of the Lung region. The common sub-fields of pulmonology include Lung Cancer, Asthma, Chronic Obstructive Pulmonary Disorder, Emphysema and many more. Join us and know the experts view of these conditions and pave the way for a healthy future generation.

Pulmonology conferences provide the opportunity to meet the experts in the field of Pulmonology across the globe and share their innovative ideas for the improvement of healthcare. The event will benefit various plenary talk sessions, exhibitions & Workshops in various aspects of pulmonology, and it will provide an excellent stage to showcase your ideas and thoughts which can incur positive impact on the participants.

The Pulmonology Market is backed by the increase in Lung disorders such as COPD, Asthma, Lung Cancer, Cystic fibrosis and their diagnostic and treatment procedures. The global pulmonology market is expected to grow by 5% in the next 10-15 years. The rise in recent trending pulmonary methods such as use of bronchial needles, bronchoscopy, magnetic bronchoscopy and methods which tends to decrease the patient discomfort drives the pulmonology market effectively. With the need for faster recovery and painless treatments the pulmonology market is in the comfort zone globally. The world-wide pulmonology market is expected to account for USD 1,665.4M by the end of 2025. It is known that the global pulmonology market has been increased and it tends to grow majorly in north and south America.

Based on applications and the disorders in the field, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory therapy, and treatment of patients on ventilators). It is obvious that the asthma segment accounts for the major share in the pulmonary market during the forecast period due to increasing prevalence of asthma globally.

The pulmonary diseases market consists of sales of respiratory diseases drugs and services by entities that produce drugs and medicines to treat respiratory diseases such as asthma, acute bronchitis, emphysema, cystic fibrosis and other diseases. Also this kind of industry includes establishments that produce anti-asthmatics and COPD drugs to prevent both acute a chronic attacks caused by respiratory diseases, cough and cold preparations to treat cough and cold.

With the market growth and the knowing the impeccable challenges in the Pulmonology, join us and stage your views in the field of Pulmonology.

Pulmonology is an internal medicine specialist that focuses on the diagnosis and treatment of respiratory system illnesses, such as those affecting the lungs, upper airways, thoracic cavity, and chest wall. Although general internists and other specialty physicians treat most common respiratory problems, internists who specialise in pulmonary medicine (often referred to as "pulmonologists") are frequently called upon to help diagnose unpredictable diseases and manage most complicated respiratory diseases.

Structure, inflammatory, infectious, and neoplastic disorders of the lung parenchyma, pleura, and airways, pulmonary vascular disease and its effect on the cardiovascular system, and detection and prevention of occupational and environmental causes of lung disease are all specialties for pulmonologists. Asthma, chronic obstructive pulmonary disease (COPD), emphysema, lung cancer, interstitial and occupational lung diseases, complex lung and pleural infections such as tuberculosis, pulmonary hypertension, and cystic fibrosis are all disorders that pulmonologists regularly evaluate and treat. Some pulmonologists specialise in sleep-disordered breathing (such as sleep apnea) and operate in sleep laboratories to help treat individuals.

Some pulmonologists work in dedicated pulmonary medicine offices or as part of a multidisciplinary group practise, where they consult with other doctors and track patients with lung disease over time. Others might work in hospitals, delivering quality care and consultation. Pulmonologists often supervise medical intensive care units in hospitals because they are specialists in respiratory failure and sophisticated procedures like mechanical ventilation. Because this job involves caring for critically ill patients, pulmonary medicine training is commonly used in combination with critical care medicine training. Critical care pulmonologists (also known as "intensivists") are uniquely qualified for work in intensive care units because of their dual training.

Market Analysis

Respiratory diseases like asthma, COPD, and lung cancer are becoming more common over the world. COPD affects roughly 65 million people worldwide, according to the World Health Organization. COPD is also on the rise in terms of prevalence, with three million fatalities in 2015, accounting for 5% of all global deaths. This opens up a lot of doors for interventional Pulmonology in different regions of the world. The demand for shorter recovery times and less discomfort during procedures and surgeries for respiratory illnesses has bolstered the interventional Pulmonology business.

Some companies place a strong priority on research and development to improve the efficiency of their products. A number of players are developing new goods in order to increase their product portfolios and maintain their market positions, resulting in market growth.

The global interventional Pulmonology market grew at a CAGR of 3% from 2016 to 2020, with prospects for the next years looking even brighter; the predicted CAGR for 2021 to 2031 is more than 4%. This is due to increase in the number of patients visiting emergency rooms as the incidence of respiratory disorders rises.

In the global interventional Pulmonology market, the United States has the largest revenue share, followed by Europe. The rising frequency of patients with COPD, asthma, and other lung disorders, together with increased investments in research and development, is the fundamental reason for their domination. Another key aspect driving demand for interventional Pulmonology is increased patient awareness.

The healthcare sector has become a focal area of attention as a result of the unusual COVID-19 pandemic scenario. The suspension of imports has a negative effect on the finances of the majority of health companies. A supply chain crisis afflicted most industries, including healthcare. The good news is that governments and business owners have begun to look for alternatives, which will help lower-income nations get materials. COVID-19 has also prompted companies and investors all around the world to reconsider their own growth strategies and skills.

The majority of nations are increasing their spending on healthcare infrastructure. Countries like India and South Africa, among others, are unable to provide adequate healthcare services due to their current healthcare infrastructure. The majority of the people in these countries live in rural areas with limited access to healthcare. As a result, these countries are expanding their spending in hospitals and improving the quality of services, especially in rural regions, resulting in increased demand for interventional Pulmonology . Furthermore, the United States maintains one of the world's largest markets for biopharmaceuticals, making it a profitable market for interventional Pulmonology . Asthma is also a frequent chronic condition among children, with youngsters having a higher prevalence than adults. Asthma affects 8.3% of children under the age of 18 in the United States. This opens up a lot of doors for interventional pulmonologists in the country.

Current Research Trends in Pulmonology

· Critical Care Medicine

· Cystic Fibrosis

· Interstitial Lung Disease

· Interventional Pulmonology

· Nontuberculous Mycobacteria & Bronchiectasis

· Obstructive Lung Disease

· Oncology Critical Care

· Precision Medicine Center of Excellence for COPD

· Pulmonary Hypertension

Some of the leading companies operating in the market are:

Medtronic Plc
Boston Scientific Corporation
Olympus Corporation
FUJIFILM Corporation
Becton, Dickinson and Company
Smiths Group Plc
Cook Medical
Vygon
PENTAX Medical
Clarus Medical
HUGER Medical Instruments co. Ltd.
Richard Wolf Corporation
Karl Storz
Taewoong medical Co. Ltd
Shanghai AoHua Pholoelectricity Endoscope Co. Ltd.

Top Universities in the world:

· Harvard Medical School

· Johns Hopkins University School of Medicine

· NYU Grossman School of Medicine

· Perelman School of Medicine at the University of Pennsylvania

· Columbia University Vagelos College of Physicians and Surgeons

· Stanford University School of Medicine

· David Geffen School of Medicine at UCLA (DGSOM)

· Mayo Clinic Alix School of Medicine

· Washington University School of Medicine in St. Louis

· UCSF School of Medicine

· Weill Cornell Graduate School of Medical Sciences

· University of Pittsburgh School of Medicine

· Northwestern University Feinberg School of Medicine

· Yale School of Medicine

· Duke University School of Medicine

· Vanderbilt University School of Medicine

· University of Chicago Pritzker School of Medicine

· Icahn School of Medicine at Mount Sinai

· University of Washington School of Medicine

· University of Michigan Medical School Ann Arbor

Top Hospitals in the world:

· Mayo Clinic - Rochester

· Cleveland Clinic

· Massachusetts General Hospital

· Toronto General (University Health Network)

· Charité - Universitätsmedizin Berlin

· The Johns Hopkins Hospital

· Universitätsspital Zürich

· Singapore General Hospital (SGH)

· Sheba Medical Center

· Karolinska Universitetssjukhuset

· Aarhus Universitetshospital

· Hôpital Universitaire Pitié Salpêtrière

· Centre Hospitalier Universitaire Vaudois

· Universitätsklinikum Heidelberg

· University of Michigan Hospitals - Michigan Medicine

· St. Luke's International Hospital

· Brigham And Women's Hospital

· The University of Tokyo Hospital

· Rigshospitalet - København

. UMC Utrecht

Metrics:

Pulsus Group is one of the world’s remarkable Scientific Conference Organizers who have their individuality on all the spectrums of Science, Technology and Business. A part of every conference series’ success specifically hangs on to how far it reaches the online community. Having an online audience is critical to make an international gathering a great success; be it research or academic or industrial.

Conferences on pulmonology show a notable number of unique visitors and page views which were proved to be a significantly successful events. Surgeons, physicians and researchers, educational institutes, hospitals and students are the main attendees of Pulsus conference series on Pulmonology as represented in the below quoted metrics.

Pulsus further extends its frontier through maintaining its every conference proceeding in its respective conference webpages and its official social media accounts. Thus, aspiring to have the participation of the international scientific and industrial communities to come and experience the pack of talks, discussions, product exhibitions and alliances.